Altered Expression of Two-Pore Domain Potassium (K2P) Channels in Cancer

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Williams, Sarah ^a   Bateman, Andrew ^b   O'Kelly, Ita ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; BRAIN CANCER; BREAST CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; ESOPHAGUS CANCER; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE UNDEREXPRESSION; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; KCNK1 GENE; KCNK10 GENE; KCNK11 GENE; KCNK12 GENE; KCNK13 GENE; KCNK14 GENE; KCNK15 GENE; KCNK16 GENE; KCNK17 GENE; KCNK18 GENE; KCNK2 GENE; KCNK3 GENE; KCNK4 GENE; KCNK5 GENE; KCNK6 GENE; KCNK7 GENE; KCNK8 GENE; KCNK9 GENE; KIDNEY CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; LYMPHOMA; MELANOMA; MYELOMA; PANCREAS CANCER; PROSTATE CANCER; SARCOMA; UTERINE CERVIX CANCER;

DATABASES, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; POTASSIUM; POTASSIUM CHANNELS, TANDEM PORE DOMAIN;

EID: 84885026250     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074589     Document Type: Article

References (96)

1. DeCoursey TE, Chandy KG, Gupta S, Cahalan MD, (1984) Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis? Nature 307: 465-468.
2. Lang F, Foller M, Lang KS, Lang PA, Ritter M, et al. (2005) Ion channels in cell proliferation and apoptotic cell death. J Membr Biol 205: 147-157.
3. Fiske J, Fomin V, Brown M, Duncan R, Sikes R, (2006) Voltage-sensitive ion channels and cancer. Cancer and Metastasis Reviews 25: 493-500.
4. Cuddapah VA, Sontheimer H, (2011) Ion channels and tranporters in cancer. 2. Ion channels and the control of cancer cell migration. American Journal of Physiology- Cell Physiology 301: 541-549.
5. Kunzelmann K, (2005) Ion channels and cancer. Journal of Membrane Biology 205: 159-173.
6. Fraser SP, Pardo LA, (2008) Ion channels: functional expression and therapeutic potential in cancer. EMBO Rep 9: 512-515.
7. Schönherr R, (2005) Clinical Relevance of Ion Channels for Diagnosis and Therapy of Cancer. J Membr Biol 205: 175-184.
8. Pardo LA, del Camino D, Sanchez A, Alves F, Bruggemann A, et al. (1999) Oncogenic potential of EAG K+ channels. EMBO J 18: 5540-5547.
9. Ousingsawat J, Spitzner M, Puntheeranurak S, Terracciano L, Tornillo L, et al. (2007) Expression of Voltage-Gated Potassium Channels in Human and Mouse Colonic Carcinoma. Clinical Cancer Research 13: 824-831.
10. Rodriguez-Rasgado JA, Acuna-Macias I, Camacho J, (2012) Eag1 channels as potential cancer biomarkers. Sensors (Basel) 12: 5986-5995.
11. D'Amico M, Gasparoli L, Arcangeli A, (2013) Potassium channels novel emerging biomarkers and targets for therapy in cancer. Recent Pat Anticancer Drug Discov 8: 53-65.
12. Hanahan D, Weinberg RA, (2000) The Hallmarks of Cancer. Cell 100: 57-70.
13. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
14. Schwab A, Fabian A, Hanley PJ, Stock C, (2012) Role of Ion Channels and Transporters in Cell Migration. Physiological Reviews 92: 1865-1913.
15. Arcangeli A, Bianchi L, Becchetti A, Faravelli L, Coronnello M, et al. (1995) A novel inward-rectifying K+ current with a cell-cycle dependence governs the resting potential of mammalian neuroblastoma cells. J Physiol 489: 455-471.
16. Wonderlin WF, Strobl JS, (1996) Potassium Channels, Proliferation and G1 Progression. Journal of Membrane Biology 154: 91-107.
17. Pardo LA, (2004) Voltage-gated potassium channels in cell proliferation. Physiology (Bethesda) 19: 285-292.
18. Wang Z, (2004) Roles of K+ channels in regulating tumour cell proliferation and apoptosis. Pflugers Arch 448: 274-286.
19. Felipe A, Vicente R, Villalonga N, Roura-Ferrer M, Martinez-Marmol R, et al. (2006) Potassium channels: new targets in cancer therapy. Cancer Detect Prev 30: 375-385.
20. Lang F, Busch GL, Ritter M, Völkl H, Waldegger S, et al. (1998) Functional Significance of Cell Volume Regulatory Mechanisms. Physiological Reviews 78: 247-306.
21. Bortner CD, Cidlowski JA, (2007) Cell shrinkage and monovalent cation fluxes: Role in apoptosis. Archives of Biochemistry and Biophysics 462: 176-188.
22. Afrasiabi E, Hietamäki M, Viitanen T, Sukumaran P, Bergelin N, et al. (2010) Expression and significance of HERG (KCNH2) potassium channels in the regulation of MDA-MB-435S melanoma cell proliferation and migration. Cellular Signalling 22: 57-64.
23. Callies C, Fels J, Liashkovich I, Kliche K, Jeggle P, et al. (2011) Membrane potential depolarization decreases the stiffness of vascular endothelial cells. Journal of Cell Science 124: 1936-1942.
24. Wang LH, Wang N, Lu XY, Liu BC, Yanda MK, et al. (2012) Rituximab inhibits Kv1.3 channels in human B lymphoma cells via activation of FcgammaRIIB receptors. Biochim Biophys Acta 1823: 505-513.
25. Jang S, Kang K, Ryu P, Lee S, (2009) Kv1.3 voltage-gated K(+) channel subunit as a potential diagnostic marker and therapeutic target for breast cancer. BMB Rep 42: 535-539.
26. Abdul M, Hoosein N, (2006) Reduced Kv1.3 Potassium Channel Expression in Human Prostate Cancer. J Membr Biol 214: 99-102.
27. Brevet M, Fucks D, Chatelain D, Regimbeau J-M, Delcenserie R, et al. (2009) Deregulation of 2 Potassium Channels in Pancreas Adenocarcinomas: Implication of KV1.3 Gene Promoter Methylation. Pancreas 38: 649-654.
28. Brevet M, Haren N, Sevestre H, Merviel P, Ouadid-Ahidouch H, (2009) DNA Methylation of Kv1.3 Potassium Channel Gene Promoter is Associated with Poorly Differentiated Breast Adenocarcinoma. Cellular Physiology and Biochemistry 24: 25-32.
29. Zheng Y, Chen L, Li J, Yu B, Su L, et al. (2011) Hypermethylated DNA as potential biomarkers for gastric cancer diagnosis. Clin Biochem 44: 1405-1411.
30. Arvind S, Arivazhagan A, Santosh V, Chandramouli BA, (2012) Differential expression of a novel voltage gated potassium channel - Kv1.5 in astrocytomas and its impact on prognosis in glioblastoma. British Journal of Neurosurgery 26: 16-20.
31. Menéndez ST, Rodrigo JP, Allonca E, García-Carracedo D, Álvarez-Alija G, et al. (2010) Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas. The Journal of Pathology 221: 402-410.
32. Jang SH, Choi C, Hong S-G, Yarishkin OV, Bae YM, et al. (2009) Silencing of Kv4.1 potassium channels inhibits cell proliferation of tumorigenic human mammary epithelial cells. Biochem Biophys Res Commun 384: 180-186.
33. Kim H-J, Jang SH, Jeong YA, Ryu PD, Kim D-Y, et al. (2010) Involvement of Kv4.1 K+ Channels in Gastric Cancer Cell Proliferation. Biological and Pharmaceutical Bulletin 33: 1754-1757.
34. Menendez ST, Villaronga MA, Rodrigo JP, Alvarez-Teijeiro S, Garcia-Carracedo D, et al. (2012) Frequent aberrant expression of the human ether a go-go (hEAG1) potassium channel in head and neck cancer: pathobiological mechanisms and clinical implications. J Mol Med (Berl) 90: 1173-1184.
35. Wu J, Wu X, Lian K, Lin B, Guo L, et al. (2012) Overexpression of potassium channel ether à go-go in human osteosarcoma. Neoplasma 59: 207-215.
36. Asher V, Warren A, Shaw R, Sowter H, Bali A, et al. (2011) The role of Eag and HERG channels in cell proliferation and apoptotic cell death in SK-OV-3 ovarian cancer cell line. Cancer Cell Int 11.
37. Agarwal J, Griesinger F, Stuhmer W, Pardo L, (2010) The potassium channel Ether a go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia. Mol Cancer 9.
38. Spitzner M, Martins JR, Soria RB, Ousingsawat J, Scheidt K, et al. (2008) Eag1 and Bestrophin 1 Are Up-regulated in Fast-growing Colonic Cancer Cells. Journal of Biological Chemistry 283: 7421-7428.
39. Ding X-W, Wang X-G, Luo H-S, Tan S-Y, Gao S, et al. (2008) Expression and Prognostic Roles of Eag1 in Resected Esophageal Squamous Cell Carcinomas. Digestive Diseases and Sciences 53: 2039-2044.
40. Ding X-W, Yan J-J, An P, Lü P, Luo H-S, (2007) Aberrant expression of ether à go-go potassium channel in colorectal cancer patients and cell lines. World Journal of Gastroenterology 13: 1257-1261.
41. Hammadi M, Chopin V, Matifat F, Dhennin-Duthille I, Chasseraud M, et al. (2012) Human ether a-gogo K(+) channel 1 (hEag1) regulates MDA-MB-231 breast cancer cell migration through Orai1-dependent calcium entry. J Cell Physiol 227: 3837-3846.
42. Wadhwa S, Wadhwa P, Dinda A, Gupta N, (2009) Differential expression of potassium ion channels in human renal cell carcinoma. International Urology and Nephrology 41: 251-257.
43. Huang X, Dubuc AM, Hashizume R, Berg J, He Y, et al. (2012) Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamics. Genes Dev 26: 1780-1796.
44. Lastraioli E, (2004) herg1 Gene and HERG1 Protein Are Overexpressed in Colorectal Cancers and Regulate Cell Invasion of Tumor Cells. Cancer Research 64: 606-611.
45. Glassmeier G, Hempel K, Wulfsen I, Bauer CK, Schumacher U, et al. (2012) Inhibition of HERG1 K+ channel protein expression decreases cell proliferation of human small cell lung cancer cells. Pflugers Arch 463: 365-376.
46. Ding X-W, Luo H-S, Luo B, Xu D-Q, Gao S, (2008) Overexpression of hERG1 in resected esophageal squamous cell carcinomas: A marker for poor prognosis. Journal of Surgical Oncology 97: 57-62.
47. Fortunato P, Pillozzi S, Tamburini A, Pollazzi L, Franchi A, et al. (2010) Irresponsiveness of two retinoblastoma cases to conservative therapy correlates with up- regulation of hERG1 channels and of the VEGF-A pathway. BMC Cancer 10.
48. Banderali U, Belke D, Singh A, Jayanthan A, Giles WR, et al. (2011) Curcumin Blocks Kv11.1 (erg) Potassium Current and Slows Proliferation in the Infant Acute Monocytic Leukemia Cell line THP-1. Cellular Physiology and Biochemistry 28: 1169-1180.
49. Shao X-D, Wu K-C, Guo X-Z, Xie M-J, Zhang J, et al. (2008) Expression and significance of HERG protein in gastric cancer. Cancer Biology & Therapy 7: 45-50.
50. Ma YG, Liu WC, Dong S, Du C, Wang XJ, et al. (2012) Activation of BK(Ca) channels in zoledronic acid-induced apoptosis of MDA-MB-231 breast cancer cells. PLoS One 7: e37451.
51. Han X, Xi L, Wang H, Huang X, Ma X, et al. (2008) The potassium ion channel opener NS1619 inhibits proliferation and induces apoptosis in A2780 ovarian cancer cells. Biochem Biophys Res Commun 375: 205-209.
52. Steinle M, Palme D, Misovic M, Rudner J, Dittmann K, et al. (2011) Ionizing radiation induces migration of glioblastoma cells by activating BK K+ channels. Radiotherapy and Oncology 101: 122-126.
53. Khaitan D, Sankpal U, Weksler B, Meister E, Romero I, et al. (2009) Role of KCNMA1 gene in breast cancer invasion and metastasis to brain. BMC Cancer 9.
54. Coiret G, Borowiec A-S, Mariot P, Ouadid-Ahidouch H, Matifat F, (2007) The Antiestrogen Tamoxifen Activates BK Channels and Stimulates Proliferation of MCF-7 Breast Cancer Cells. Mol Pharmacol 71: 843-851.
55. Cambien B, Rezzonico R, Vitale S, Rouzaire-Dubois B, Dubois J, et al. (2008) Silencing of hSlo potassium channels in human osteosarcoma cells promotes tumorigenesis. Int J Cancer 123: 365-371.
56. Chantome A, Girault A, Potier M, Collin C, Vaudin P, et al. (2009) KCa2.3 channel-dependent hyperpolarization increases melanoma cell motility. Experimental Cell Research 315: 3620-3630.
57. Potier M, Joulin V, Roger S, Besson P, Jourdan M-L, et al. (2006) Identification of SK3 channel as a new mediator of breast cancer cell migration. Molecular Cancer Therapeutics 5: 2946-2953.
58. Potier M, Tran TA, Chantome A, Girault A, Joulin V, et al. (2010) Altered SK3/KCa2.3-mediated migration in adenomatous polyposis coli (Apc) mutated mouse colon epithelial cells. Biochem Biophys Res Commun 397: 42-47.
59. Catacuzzeno L, Aiello F, Fioretti B, Sforna L, Castigli E, et al. (2011) Serum-activated K and Cl currents underlay U87-MG glioblastoma cell migration. Journal of Cellular Physiology 226: 1926-1933.
60. Schmidt J, Friebel K, Schonherr R, Coppolino MG, Bosserhoff A-K, (2010) Migration-associated secretion of melanoma inhibitory activity at the cell rear is supported by KCa3.1 potassium channels. Cell Res 20: 1224-1238.
61. Lai W, Chen S, Wu H, Guan Y, Liu L, et al. (2011) PRL-3 promotes the proliferation of LoVo cells via the upregulation of KCNN4 channels. Oncol Rep 26: 909-917.
62. Lallet-Daher H, Roudbaraki M, Bavencoffe A, Mariot P, Gackiere F, et al. (2009) Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry. Oncogene 28: 1792-1806.
63. Faouzi M, Chopin V, Ahidouch A, Ouadid-Ahidouch H, (2010) Intermediate Ca2+-Sensitive K+ Channels are Necessary for Prolactin-Induced Proliferation in Breast Cancer Cells. Journal of Membrane Biology 234: 47-56.
64. Lee I, Park C, Kang WK, (2010) Knockdown of Inwardly Rectifying Potassium Channel Kir2.2 Suppresses Tumorigenesis by Inducing Reactive Oxygen Species-Mediated Cellular Senescence. Molecular Cancer Therapeutics 9: 2951-2959.
65. Stringer BK, Cooper AG, Shepard SB, (2001) Overexpression of the G-Protein Inwardly Rectifying Potassium Channel 1 (GIRK1) in Primary Breast Carcinomas Correlates with Axillary Lymph Node Metastasis. Cancer Research 61: 582-588.
66. Plummer H, Dhar M, Cekanova M, Schuller H, (2005) Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines. BMC Cancer 5.
67. Choi M, Scholl UI, Yue P, Björklund P, Zhao B, et al. (2011) K+ Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension. Science 331: 768-772.
68. Tan G, Sun S-q, Yuan D-l, (2008) Expression of Kir 4.1 in human astrocytic tumors: Correlation with pathologic grade. Biochem Biophys Res Commun 367: 743-747.
69. Veeravalli KK, Ponnala S, Chetty C, Tsung AJ, Gujrati M, et al. (2012) Integrin α9β1-mediated cell migration in glioblastoma via SSAT and Kir4.2 potassium channel pathway. Cellular Signalling 24: 272-281.
70. Park S-H, Ramachandran S, Kwon S-H, Cha S-D, Seo EW, et al. (2008) Upregulation of ATP-sensitive potassium channels for estrogen-mediated cell proliferation in human uterine leiomyoma cells. Gynecological Endocrinology 24: 250-256.
71. Huang L, Li B, Li W, Guo H, Zou F, (2009) ATP-sensitive potassium channels control glioma cells proliferation by regulating ERK activity. Carcinogenesis 30: 737-744.
72. Nunez M, Medina V, Cricco G, Croci M, Cocca C, et al. (2013) Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231. BMC Pharmacology and Toxicology 14.
73. Suzuki Y, Inoue T, Murai M, Suzuki-Karasaki M, Ochiai T, et al. (2012) Depolarization potentiates TRAIL-induced apoptosis in human melanoma cells: role for ATP-sensitive K+ channels and endoplasmic reticulum stress. Int J Oncol 41: 465-475.
74. Voloshyna I, Besana A, Castillo M, Matos T, Weinstein IB, et al. (2008) TREK-1 is a novel molecular target in prostate cancer. Cancer Res 68: 1197-1203.
75. Nogueira EF, Gerry D, Mantero F, Mariniello B, Rainey WE, (2010) The role of TASK1 in aldosterone production and its expression in normal adrenal and aldosterone-producing adenomas. Clin Endocrinol (Oxf) 73: 22-29.
76. Alvarez-Baron CP, Jonsson P, Thomas C, Dryer SE, Williams C, (2011) The Two-Pore Domain Potassium Channel KCNK5: Induction by Estrogen Receptor α and Role in Proliferation of Breast Cancer Cells. Molecular Endocrinology 25: 1326-1336.
77. Mu D, Chen L, Zhang X, See L-H, Koch CM, et al. (2003) Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. Cancer Cell 3: 297-302.
78. Kim CJ, Cho YG, Jeong SW, Kim YS, Kim SY, et al. (2004) Altered expression of KCNK9 in colorectal cancers. APMIS 112: 588-594.
79. Kosztka L, Rusznak Z, Nagy D, Nagy Z, Fodor J, et al. (2011) Inhibition of TASK-3 (KCNK9) channel biosynthesis changes cell morphology and decreases both DNA content and mitochondrial function of melanoma cells maintained in cell culture. Melanoma Res 21: 308-322.
80. Lee GW, Park HS, Kim EJ, Cho YW, Kim GT, et al. (2012) Reduction of breast cancer cell migration via up-regulation of TASK-3 two-pore domain K+ channel. Acta Physiologica 204: 513-524.
81. Enyedi P, Czirják G, (2010) Molecular Background of Leak K+ Currents: Two-Pore Domain Potassium Channels. Physiological Reviews 90: 559-605.
82. Goldstein SA, Bockenhauer D, O'Kelly I, Zilberberg N, (2001) Potassium leak channels and the KCNK family of two-P-domain subunits. Nat Rev Neurosci 3: 175-84.
83. Bittner S, Budde T, Wiendl H, Meuth SG, (2010) From the background to the spotlight: TASK channels in pathological conditions. Brain Pathol 6: 999-1009.
84. Pei L, Wiser O, Slavin A, Mu D, Powers S, et al. (2003) Oncogenic potential of TASK3 (Kcnk9) depends on K+ channel function. Proc Natl Acad Sci U S A 100: 7803-7807.
85. Pocsai K, Kosztka L, Bakondi G, Gonczi M, Fodor J, et al. (2006) Melanoma cells exhibit strong intracellular TASK-3-specific immunopositivity in both tissue sections and cell culture. Cell Mol Life Sci 63: 2364-2376.
86. Lauritzen I, Zanzouri M, Honore E, Duprat F, Ehrengruber MU, et al. (2003) K+-dependent cerebellar granule neuron apoptosis. Role of task leak K+ channels. J Biol Chem 278: 32068-32076.
87. Williams C, Edvardsson K, Lewandowski SA, Strom A, Gustafsson J-A, (2007) A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells. Oncogene 27: 1019-1032.
88. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, et al. (2007) Oncomine 3.0: Genes, Pathways, and Networks in a Collection of 18,000 Cancer Gene Expression Profiles. Neoplasia 9: 166-180.
89. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, et al. (2004) ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6: 1-6.
90. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr, accessed on 14/07/2013.
91. Goldstein SA, Bayliss DA, Kim D, Lesage F, Plant LD, et al. (2005) International Union of Pharmacology. LV. Nomenclature and molecular relationships of two-P potassium channels. Pharmacol Rev 57: 527-540.
92. O'Kelly I, Stephens RH, Peers C, Kemp PJ, (1999) Potential identification of the O2-sensitive K+ current in a human neuroepithelial body-derived cell line. American Journal of Physiology- Lung Cellular and Molecular Physiology 276: L96-L104.
93. Duprat F, Girard C, Jarretou G, Lazdunski M, (2005) Pancreatic two P domain K+ channels TALK-1 and TALK-2 are activated by nitric oxide and reactive oxygen species. J Physiol 562: 235-244.
94. Campanucci VA, Brown ST, Hudasek K, O'Kelly IM, Nurse CA, et al. (2005) O2 sensing by recombinant TWIK-related halothane-inhibitable K+ channel-1 background K+ channels heterologously expressed in human embryonic kidney cells. Neuroscience 135: 1087-1094.
95. Duprat F, Lauritzen I, Patel A, Honoré E, (2007) The TASK background K2P channels: chemo- and nutrient sensors. Trends Neurosci 11: 573-80.
96. Mant A, Williams S, Roncoroni L, Lowry E, Johnson D, et al. (2012) N-glycosylation-dependent control of functional expression of background potassium channels K2P3.1 and K2P9.1. Journal of Biological Chemistry.